An effective and more affordable treatment for lung cancer may not gain approval after the Food and Drug Administration (FDA) complained about the lack of black people in its clinical trial, with a t… [+6735 chars]
FDA Slows Approval Of Affordable Cancer Drug In The Name Of Racial Equity – The Daily Wire